Hepatocyte growth factor suppresses production of reactive oxygen species and release of eosinophil-derived neurotoxin from human eosinophils

Wataru Ito, Masahide Takeda, Miyoshi Fujita, Yumiko Kamada, Hikari Kato, Takahito Chiba, Kazutoshi Yamaguchi, Shigeharu Ueki, Hiroyuki Kayaba, Arihiko Kanehiro, Junichi Chihara

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Reactive oxygen species (ROS) and eosinophilic granule proteins such as eosinophil-derived neurotoxin (EDN) are known to damage bronchial tissue and cause airway hyperresponsiveness (AHR) in asthma. Hepatocyte growth factor (HGF) regulates various biological activities and is known to be a multifunctional factor. In our previous study, we found that HGF suppressed allergic airway inflammation and AHR in a murine model of asthma. However, there have been few reports regarding the detailed mechanism of the anti-allergic effect of HGF in asthma. In this study, we investigated the potential of recombinant HGF to regulate the production of ROS and the release of EDN from human eosinophils. Methods: Eosinophils were isolated from subjects with mild eosinophilia by modified CD16-negative selection. We investigated the expression of CD69, an activation marker of eosinophils, on eosinophils, using flow cytometry. Further, ROS production from eosinophils was analyzed using luminol-dependent chemiluminescence, and EDN release was measured by ELISA. Results: Treatment with HGF suppressed interleukin-5-induced upregulation of CD69 expression, ROS production and EDN release from human eosinophils. Conclusion: Taken together, these data suggest that in asthma, HGF attenuates allergic airway inflammation and AHR through at least the suppression of ROS production and EDN release from eosinophils.

Original languageEnglish
Pages (from-to)331-337
Number of pages7
JournalInternational Archives of Allergy and Immunology
Volume147
Issue number4
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Eosinophil-Derived Neurotoxin
Hepatocyte Growth Factor
Eosinophils
Reactive Oxygen Species
Asthma
Inflammation
Luminol
Anti-Allergic Agents
Interleukin-5
Eosinophilia
Luminescence
Flow Cytometry
Up-Regulation
Enzyme-Linked Immunosorbent Assay

Keywords

  • Asthma
  • Degranulation
  • Eosinophil
  • Hepatocyte growth factor
  • Reactive oxygen species

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Hepatocyte growth factor suppresses production of reactive oxygen species and release of eosinophil-derived neurotoxin from human eosinophils. / Ito, Wataru; Takeda, Masahide; Fujita, Miyoshi; Kamada, Yumiko; Kato, Hikari; Chiba, Takahito; Yamaguchi, Kazutoshi; Ueki, Shigeharu; Kayaba, Hiroyuki; Kanehiro, Arihiko; Chihara, Junichi.

In: International Archives of Allergy and Immunology, Vol. 147, No. 4, 11.2008, p. 331-337.

Research output: Contribution to journalArticle

Ito, W, Takeda, M, Fujita, M, Kamada, Y, Kato, H, Chiba, T, Yamaguchi, K, Ueki, S, Kayaba, H, Kanehiro, A & Chihara, J 2008, 'Hepatocyte growth factor suppresses production of reactive oxygen species and release of eosinophil-derived neurotoxin from human eosinophils', International Archives of Allergy and Immunology, vol. 147, no. 4, pp. 331-337. https://doi.org/10.1159/000144041
Ito, Wataru ; Takeda, Masahide ; Fujita, Miyoshi ; Kamada, Yumiko ; Kato, Hikari ; Chiba, Takahito ; Yamaguchi, Kazutoshi ; Ueki, Shigeharu ; Kayaba, Hiroyuki ; Kanehiro, Arihiko ; Chihara, Junichi. / Hepatocyte growth factor suppresses production of reactive oxygen species and release of eosinophil-derived neurotoxin from human eosinophils. In: International Archives of Allergy and Immunology. 2008 ; Vol. 147, No. 4. pp. 331-337.
@article{4c660e89e1c945d09fe33ca23217ce73,
title = "Hepatocyte growth factor suppresses production of reactive oxygen species and release of eosinophil-derived neurotoxin from human eosinophils",
abstract = "Background: Reactive oxygen species (ROS) and eosinophilic granule proteins such as eosinophil-derived neurotoxin (EDN) are known to damage bronchial tissue and cause airway hyperresponsiveness (AHR) in asthma. Hepatocyte growth factor (HGF) regulates various biological activities and is known to be a multifunctional factor. In our previous study, we found that HGF suppressed allergic airway inflammation and AHR in a murine model of asthma. However, there have been few reports regarding the detailed mechanism of the anti-allergic effect of HGF in asthma. In this study, we investigated the potential of recombinant HGF to regulate the production of ROS and the release of EDN from human eosinophils. Methods: Eosinophils were isolated from subjects with mild eosinophilia by modified CD16-negative selection. We investigated the expression of CD69, an activation marker of eosinophils, on eosinophils, using flow cytometry. Further, ROS production from eosinophils was analyzed using luminol-dependent chemiluminescence, and EDN release was measured by ELISA. Results: Treatment with HGF suppressed interleukin-5-induced upregulation of CD69 expression, ROS production and EDN release from human eosinophils. Conclusion: Taken together, these data suggest that in asthma, HGF attenuates allergic airway inflammation and AHR through at least the suppression of ROS production and EDN release from eosinophils.",
keywords = "Asthma, Degranulation, Eosinophil, Hepatocyte growth factor, Reactive oxygen species",
author = "Wataru Ito and Masahide Takeda and Miyoshi Fujita and Yumiko Kamada and Hikari Kato and Takahito Chiba and Kazutoshi Yamaguchi and Shigeharu Ueki and Hiroyuki Kayaba and Arihiko Kanehiro and Junichi Chihara",
year = "2008",
month = "11",
doi = "10.1159/000144041",
language = "English",
volume = "147",
pages = "331--337",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Hepatocyte growth factor suppresses production of reactive oxygen species and release of eosinophil-derived neurotoxin from human eosinophils

AU - Ito, Wataru

AU - Takeda, Masahide

AU - Fujita, Miyoshi

AU - Kamada, Yumiko

AU - Kato, Hikari

AU - Chiba, Takahito

AU - Yamaguchi, Kazutoshi

AU - Ueki, Shigeharu

AU - Kayaba, Hiroyuki

AU - Kanehiro, Arihiko

AU - Chihara, Junichi

PY - 2008/11

Y1 - 2008/11

N2 - Background: Reactive oxygen species (ROS) and eosinophilic granule proteins such as eosinophil-derived neurotoxin (EDN) are known to damage bronchial tissue and cause airway hyperresponsiveness (AHR) in asthma. Hepatocyte growth factor (HGF) regulates various biological activities and is known to be a multifunctional factor. In our previous study, we found that HGF suppressed allergic airway inflammation and AHR in a murine model of asthma. However, there have been few reports regarding the detailed mechanism of the anti-allergic effect of HGF in asthma. In this study, we investigated the potential of recombinant HGF to regulate the production of ROS and the release of EDN from human eosinophils. Methods: Eosinophils were isolated from subjects with mild eosinophilia by modified CD16-negative selection. We investigated the expression of CD69, an activation marker of eosinophils, on eosinophils, using flow cytometry. Further, ROS production from eosinophils was analyzed using luminol-dependent chemiluminescence, and EDN release was measured by ELISA. Results: Treatment with HGF suppressed interleukin-5-induced upregulation of CD69 expression, ROS production and EDN release from human eosinophils. Conclusion: Taken together, these data suggest that in asthma, HGF attenuates allergic airway inflammation and AHR through at least the suppression of ROS production and EDN release from eosinophils.

AB - Background: Reactive oxygen species (ROS) and eosinophilic granule proteins such as eosinophil-derived neurotoxin (EDN) are known to damage bronchial tissue and cause airway hyperresponsiveness (AHR) in asthma. Hepatocyte growth factor (HGF) regulates various biological activities and is known to be a multifunctional factor. In our previous study, we found that HGF suppressed allergic airway inflammation and AHR in a murine model of asthma. However, there have been few reports regarding the detailed mechanism of the anti-allergic effect of HGF in asthma. In this study, we investigated the potential of recombinant HGF to regulate the production of ROS and the release of EDN from human eosinophils. Methods: Eosinophils were isolated from subjects with mild eosinophilia by modified CD16-negative selection. We investigated the expression of CD69, an activation marker of eosinophils, on eosinophils, using flow cytometry. Further, ROS production from eosinophils was analyzed using luminol-dependent chemiluminescence, and EDN release was measured by ELISA. Results: Treatment with HGF suppressed interleukin-5-induced upregulation of CD69 expression, ROS production and EDN release from human eosinophils. Conclusion: Taken together, these data suggest that in asthma, HGF attenuates allergic airway inflammation and AHR through at least the suppression of ROS production and EDN release from eosinophils.

KW - Asthma

KW - Degranulation

KW - Eosinophil

KW - Hepatocyte growth factor

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=56549125670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56549125670&partnerID=8YFLogxK

U2 - 10.1159/000144041

DO - 10.1159/000144041

M3 - Article

C2 - 18622140

AN - SCOPUS:56549125670

VL - 147

SP - 331

EP - 337

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - 4

ER -